CleanFUZE is a new load-bearing polymer from which any orthopedic or dental implant can be engineered. Clinical tests show that the biomaterial eliminates 99.9 percent of MRSA bacterium while prevention biofilm adhesion.
The technology will be introduced in the European Union in 2013 with subsequent FDA clearance in 2014.
More Articles on Orthopedic Devices:
Will Medical Device Companies Benefit From Healthcare Reform?
7 Ways to Market Artificial Discs in Spine Practices
TranS1 Names Dr. Stephanie Fitts Vice President of Regulatory, Quality and Compliance
At the Becker’s 32nd Annual Meeting: The Business and Operations of ASCs, taking place October 29-31 in Chicago, ASC leaders, surgeons and healthcare executives will explore strategies to drive growth, enhance operational performance, navigate reimbursement challenges and prepare for the future of ambulatory surgery. Apply for complimentary registration now.